Medication info
Esomeprazole Magnesium Hydrate 20 mg Tablet

Esomeprazole Magnesium Hydrate 20 mg Tablet

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›21.69mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Pink oval film-coated tablets
Packaging
14 tablets (7 tablets/Alu-Alu x 2)
Approval status
Active

MFDS item code 201507272 · Approved 2015.10.21 · Insurance code 670607320

Summary

Main use
Treatment and prevention of acid-related disorders, H. pylori infection and ulcers, and gastrointestinal disorders caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medication 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medication must not exceed 20 mg. 6. Older adults No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue taking it for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medication to children under 12 years of age.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment and prevention of acid-related disorders, H. pylori infection and ulcers, and gastrointestinal disorders caused by anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
  • rebleeding.
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, especially for erosive esophagitis and long-term maintenance therapy for prevention of recurrence. It also helps alleviate symptoms of gastroesophageal reflux without esophagitis. This drug is used in combination with antibiotics for the treatment of duodenal ulcers caused by Helicobacter pylori infection and prevention of recurrent peptic ulcers. It is effective for treating and preventing gastric and duodenal ulcers associated with upper gastrointestinal symptoms due to NSAID use. Additionally, it is used for the treatment of Zollinger-Ellison syndrome and maintenance therapy for the prevention of rebleeding from gastric and duodenal ulcers. In summary, this medication is widely used for treating gastrointestinal and esophageal-related diseases and for preventing ulcers.

Dosage and Administration

Adult dosage

1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medication 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medication must not exceed 20 mg. 6. Older adults No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue taking it for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medication to children under 12 years of age.

Precautions

This medication should not be used in patients with allergies or hypersensitivity to certain ingredients. In particular, patients sensitive to benzimidazole derivatives, penicillin antibiotics, or macrolide antibiotics should not receive this medication. Patients taking certain heart-related medications or antivirals, nursing mothers, and patients with a history of myocardial infarction should not use this drug. This medication contains a dye called Yellow No. 5, and patients with a history of allergy to this component should use it with caution. Various side effects may occur when taking this medication, including headache, dizziness, abdominal pain, diarrhea, nausea, skin rash, and itching. If these symptoms are severe or persistent, consult healthcare professionals. Although rare, blood abnormalities, severe allergic reactions, liver dysfunction, and severe skin reactions may occur, so if abnormal symptoms arise, immediate medical care should be sought. This drug suppresses gastric acid, which may increase the risk of bacterial infections in the gastrointestinal tract, so if diarrhea persists for a long time, notify healthcare professionals. Long-term use may increase the risk of fractures; therefore, patients with osteoporosis should have regular bone density tests. Additionally, prolonged use may lower blood magnesium levels, so patients who take it long-term or are at risk for hypomagnesemia should be monitored through blood tests. This medication has a high potential for drug interactions, so patients taking anticoagulants, antiepileptics, certain antibiotics, or antivirals should inform their doctor. During pregnancy, this medication should be used cautiously as its safety for the fetus has not been fully established, and nursing mothers should avoid taking it. In case of overdose, there is no specific antidote; therefore, one should go to the hospital immediately for appropriate treatment and keep it out of reach of children to prevent accidents.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headaches, dizziness, sensory disturbances, drowsiness, taste disorders, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, flu-like syndrome, general edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid gland swelling, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, anxiety, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, sensory disturbances, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, parosmia, ageusia, dysgeusia, abnormal urination, albuminuria, cystitis, dysuria, fungal infections, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it in this manner will help maintain its effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

14 tablets (7 tablets/Alu-Alu x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.